Relation of Implantation Site to Placental Site

Placenta Implantation Site Clinical Trial

Official title:

Relation of Implantation Site to Placental Site With or Without Cesarean Section Scar

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02765984
• Other study ID #: 142
• Status: Recruiting
• Phase: N/A
• First received: April 30, 2016
• Last updated: March 6, 2018
• Start date: May 1, 2017
• Est. completion date: December 2018

Study information

• Verified date: March 2018
• Source: Cairo University
• Contact: Ahmed Maged, MD
• Phone: 0020201005227404
• Email: dr_ahmedmaged[@]kasralainy.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Trans vaginal ultrasound with a partially full bladder will be done at gestational age earlier than 10 weeks to assess the site of intrauterine gestational sac to the endometrial cavity and the distance between the implantation site and the internal cervical os . Doppler assessment of the retrochorionic blood flow at the area behind the maximum chorionic tissue to detect resistance index.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• Single intrauterine pregnancy

• Gestational age less than 10 weeks

Exclusion Criteria:

• Any condition distorting uterine cavity as myoma, uterine anomalies.

• Absent fetal pulsations

• Any condition needing termination of early pregnancy as molar pregnancy or severe deteriorating maternal disease

Related Conditions & MeSH terms

• Placenta Implantation Site

Intervention

Device:
• Transvaginal ultrasound
transvaginal ultrasound done before 10 weeks gestational age measuring the distance between the lower end of the hyperechoic trophoblast ring of the gestational sac and the inner cervical os

Locations

Country	Name	City	State
Egypt	Ahmed Maged	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Distance between the implantation site and the internal cervical os		10 weeks to 40 weeks gestational age